Inventor · disambiguated record
Robert Scott
Also filed as: SCOTT ROBERT · SCOTT ROBERT A · SCOTT ROBERT A D
2 granted patents·7 pending applications·0 citations·filing 2006–2021
25Inventor score
Files withSCOTT ROBERT A D4CERENIS THERAPEUTICS S A & NIPPON CHEMIPHAR CO LTD1FENTON MARCUS BRIAN MAYHALL1GLAXOSMITHKLINE IP DEV LTD1SCOTT ROBERT A1
Top patents by PatentIndex Score
9 records- 0155US2023322779A1Imidazonaphthyridines and imidazopyridopyrimidines as ifnar2 agonists for treating sars-cov-2 infectionsGLAXOSMITHKLINE IP DEV LTD·Filed 2021·Application pending·0 cites
- 0250US8252840B2Methods of derivatives of probucol for the treatment of type II diabetesSCOTT ROBERT A D·Filed 2008·Granted Aug 28, 2012·0 cites·27 claims
- 0348US2007213303A1Methods for reducing platelet activation and for the treatment of thrombotic eventsSCOTT ROBERT A·Filed 2006·Application pending·0 cites
- 0444US2012270275A1Systems and methods for treating biomass and calculating ethanol yieldFENTON MARCUS BRIAN MAYHALL·Filed 2012·Application pending·0 cites
- 0540US11219216B2Method of improving tolerance of plants to herbicides using seed insecticide treatmentsUNIV ARKANSAS·Filed 2016·Granted Jan 11, 2022·0 cites·8 claims
- 0638US2012295973A1Methods and compositions of derivatives of probucol for the treatment of diabetesSCOTT ROBERT A D·Filed 2012·Application pending·0 cites
- 0735US2011092517A1Use of PPAR Delta Ligands for the Treatment or Prevention of Inflammation or Energy Metabolism/Production Related DiseasesCERENIS THERAPEUTICS S A & NIPPON CHEMIPHAR CO LTD·Filed 2010·Application pending·0 cites
- 0832US2011319349A1Methods for Reducing Platelet Activation and for the Treatment of Thrombotic EventsSCOTT ROBERT A D·Filed 2011·Application pending·0 cites
- 0930US2008280985A1Methods and Compositions Using Certain Phenolic Derivatives for the Treatment of DiabetesSCOTT ROBERT A D·Filed 2008·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Robert Scott files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →